Daniel Hell mostly deals with Neuroscience, Psychosis, Schizophrenia, Major depressive disorder and Psychotomimetic. His work deals with themes such as Haloperidol, Mismatch negativity and Memoria, Cognition, which intersect with Psychosis. His Schizophrenia study combines topics from a wide range of disciplines, such as First episode, Functional neuroimaging, Brain activity and meditation and Visual memory.
His Major depressive disorder study is associated with Psychiatry. Daniel Hell usually deals with Neuroimaging and limits it to topics linked to Neuropsychology and Dorsolateral prefrontal cortex and Audiology. His Audiology research is multidisciplinary, incorporating elements of Magnetoencephalography and Electroencephalography.
Daniel Hell mainly focuses on Psychiatry, Neuroscience, Schizophrenia, Psychosis and Audiology. His Psychiatry research focuses on subjects like Clinical psychology, which are linked to Personality disorders, Social support, Psychodynamics and Quality of life. His research in Neuroscience intersects with topics in Internal medicine, Cerebral blood flow and MDMA.
His research in Schizophrenia intersects with topics in Cognition and Month follow up. His Psychosis study typically links adjacent topics like First episode. His study in Audiology is interdisciplinary in nature, drawing from both Developmental psychology, Psychopathology, Panic disorder and Electroencephalography.
His primary scientific interests are in Psychiatry, Major depressive disorder, Clinical psychology, Cognition and Depression. His Psychiatry research focuses on Functional imaging and how it relates to Cortex and Default mode network. His Major depressive disorder research includes elements of Anterior cingulate cortex and Neuroimaging.
His Anterior cingulate cortex study results in a more complete grasp of Neuroscience. His Cognition research includes themes of Hallucinogen and Psilocybin. His Hemodynamics research incorporates elements of Psychosis, Frontal lobe and Schizophrenia.
His primary areas of study are Major depressive disorder, Psychiatry, Depression, Neuroscience and Anterior cingulate cortex. His Major depressive disorder study combines topics in areas such as Neuroimaging, Psychotropic drug and Major depressive episode. His work in Neuroimaging covers topics such as Hypoactivity which are related to areas like Audiology.
His studies deal with areas such as Internal medicine, Incidence, Functional magnetic resonance imaging and Functional imaging as well as Psychiatry. His research integrates issues of Odds ratio, Perception, Ventral striatum, Neural correlates of consciousness and Precuneus in his study of Depression. Default mode network, Cortex, Ventromedial prefrontal cortex and Posterior cingulate are the subjects of his Neuroscience studies.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.
Franz X. Vollenweider;Margreet F. I. Vollenweider-Scherpenhuyzen;Andreas Bäbler;Helen Vogel.
Neuroreport (1998)
Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, first-episode, productive schizophrenia.
Roberto D. Pascual-Marqui;Dietrich Lehmann;Thomas Koenig;Kieko Kochi.
Psychiatry Research-neuroimaging (1999)
Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers: Implications for Models of Cognitive Deficits in Schizophrenia
Daniel Umbricht;Liselotte Schmid;Rene Koller;Franz X. Vollenweider.
Archives of General Psychiatry (2000)
Imbalance between Left and Right Dorsolateral Prefrontal Cortex in Major Depression Is Linked to Negative Emotional Judgment : An fMRI Study in Severe Major Depressive Disorder
Simone Grimm;Johannes Beck;Daniel Schuepbach;Daniel Hell.
Biological Psychiatry (2008)
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)
F.X. Vollenweider;K.L. Leenders;I. Øye;D. Hell.
European Neuropsychopharmacology (1997)
Altered Negative BOLD Responses in the Default-Mode Network during Emotion Processing in Depressed Subjects
Simone Grimm;Peter Boesiger;Johannes Beck;Daniel Schuepbach.
Neuropsychopharmacology (2009)
Brain areas and time course of emotional processing.
Michaela Esslen;Roberto D. Pascual-Marqui;D. Hell;Kieko Kochi.
NeuroImage (2004)
Increased self-focus in major depressive disorder is related to neural abnormalities in subcortical-cortical midline structures
Simone Grimm;Jutta Ernst;Peter Boesiger;Daniel Schuepbach.
Human Brain Mapping (2009)
Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.
Matthias E Liechti;Matthias R Saur;Alex Gamma;Daniel Hell.
Neuropsychopharmacology (2000)
5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.
Franz X Vollenweider;Peter Vontobel;Daniel Hell;Klaus L Leenders.
Neuropsychopharmacology (1999)
University of Zurich
University of Ottawa
University of California, San Diego
University of Zurich
Vanderbilt University
University Medical Center Groningen
Humboldt-Universität zu Berlin
ETH Zurich
University of Zurich
University of Zurich
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: